Wilms’ tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Wilms’ tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer
Authors
Keywords
-
Journal
Immunotherapy
Volume 8, Issue 11, Pages 1309-1320
Publisher
Future Medicine Ltd
Online
2016-12-20
DOI
10.2217/imt-2016-0031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Wilms tumor protein 1 (WT1) — Not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma
- (2016) Eliane Tabea Taube et al. GYNECOLOGIC ONCOLOGY
- Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells
- (2015) Shin Kan et al. BMC CANCER
- Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer
- (2015) Shuhei Mayanagi et al. CANCER SCIENCE
- Strategies to relieve immunosuppression in pancreatic cancer
- (2015) Max Schnurr et al. Immunotherapy
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma
- (2015) Richard G. Everson et al. NEURO-ONCOLOGY
- Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy
- (2015) Shintaro Tsukinaga WORLD JOURNAL OF GASTROENTEROLOGY
- Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis
- (2015) Xiao-wei Qi et al. Scientific Reports
- Mechanisms of transcriptional regulation by WT1 (Wilms’ tumour 1)
- (2015) Eneda Toska et al. BIOCHEMICAL JOURNAL
- Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis
- (2014) Masanori Kobayashi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Treatment with Chemotherapy and Dendritic Cells Pulsed with Multiple Wilms' Tumor 1 (WT1)-Specific MHC Class I/II-Restricted Epitopes for Pancreatic Cancer
- (2014) S. Koido et al. CLINICAL CANCER RESEARCH
- Wilms Tumor Gene (WT1) Peptide–based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer
- (2014) Sumiyuki Nishida et al. JOURNAL OF IMMUNOTHERAPY
- Generation of the epicardial lineage from human pluripotent stem cells
- (2014) Alec D Witty et al. NATURE BIOTECHNOLOGY
- Pancreatic cancer and its stroma: A conspiracy theory
- (2014) Zhihong Xu WORLD JOURNAL OF GASTROENTEROLOGY
- S-1 in the treatment of pancreatic cancer
- (2014) Kentaro Sudo WORLD JOURNAL OF GASTROENTEROLOGY
- The Wilms’ tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression
- (2014) Kay-Dietrich Wagner et al. Nature Communications
- Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
- (2014) E. R. Lutz et al. Cancer Immunology Research
- Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
- (2014) Irena Adkins et al. OncoImmunology
- Trial watch: Dendritic cell-based anticancer therapy
- (2014) Norma Bloy et al. OncoImmunology
- Chemoimmunotherapy targeting Wilms’ tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer
- (2014) Shigeo Koido et al. OncoImmunology
- Deciphering the role of stroma in pancreatic cancer
- (2013) Meghna Waghray et al. CURRENT OPINION IN GASTROENTEROLOGY
- Role of Immune Cells and Immune-Based Therapies in Pancreatitis and Pancreatic Ductal Adenocarcinoma
- (2013) Lei Zheng et al. GASTROENTEROLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- Mucin-based Targeted Pancreatic Cancer Therapy
- (2012) Maria P. Torres et al. CURRENT PHARMACEUTICAL DESIGN
- Active Specific Immunotherapy Targeting the Wilms' Tumor Protein 1 (WT1) for Patients with Hematological Malignancies and Solid Tumors: Lessons from Early Clinical Trials
- (2012) A. Van Driessche et al. ONCOLOGIST
- Cytotoxic T Lymphocytes Efficiently Recognize Human Colon Cancer Stem-Like Cells
- (2011) Satoko Inoda et al. AMERICAN JOURNAL OF PATHOLOGY
- A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma
- (2011) Lutz Eric et al. ANNALS OF SURGERY
- Gemcitabine enhances Wilms’ tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response
- (2011) Akitaka Takahara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Current Immunotherapeutic Approaches in Pancreatic Cancer
- (2011) Shigeo Koido et al. Clinical & Developmental Immunology
- Immunotherapy synergizes with chemotherapy targeting pancreatic cancer
- (2011) Shigeo Koido et al. Immunotherapy
- Cancer immunotherapy – revisited
- (2011) W. Joost Lesterhuis et al. NATURE REVIEWS DRUG DISCOVERY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and Immunologic Evaluation of Dendritic Cell–Based Immunotherapy in Combination With Gemcitabine and/or S-1 in Patients With Advanced Pancreatic Carcinoma
- (2011) Yukino Kimura et al. PANCREAS
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Wilms’ tumor protein Wt1 regulates the Interleukin-10 (IL-10) gene
- (2010) Lina K. Sciesielski et al. FEBS LETTERS
- Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells
- (2010) Yoshihiko Hirohashi et al. Immunotherapy
- Induction of cytotoxic T lymphocytes against ovarian cancer-initiating cells
- (2010) Desheng Weng et al. INTERNATIONAL JOURNAL OF CANCER
- WT1 (Wilms' Tumor Gene 1): Biology and Cancer Immunotherapy
- (2010) H. Sugiyama JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Phase 1 Trial of Wilms Tumor 1 (WT1) Peptide Vaccine and Gemcitabine Combination Therapy in Patients With Advanced Pancreatic or Biliary Tract Cancer
- (2010) Miho Kaida et al. JOURNAL OF IMMUNOTHERAPY
- Advanced pancreatic carcinoma: current treatment and future challenges
- (2010) Anastasios Stathis et al. Nature Reviews Clinical Oncology
- Whole tumor antigen vaccines
- (2010) Cheryl Lai-Lai Chiang et al. SEMINARS IN IMMUNOLOGY
- HER2 overexpression correlates with survival after curative resection of pancreatic cancer
- (2009) Masahiro Komoto et al. CANCER SCIENCE
- Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer
- (2009) Motoki Miyazawa et al. CANCER SCIENCE
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Natural killer cells kill human melanoma cells with characteristics of cancer stem cells
- (2009) G. Pietra et al. INTERNATIONAL IMMUNOLOGY
- WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor
- (2009) Yusuke Oji et al. INTERNATIONAL JOURNAL OF CANCER
- CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells
- (2009) Sung Pil Hong et al. INTERNATIONAL JOURNAL OF CANCER
- Efficient Killing of Human Colon Cancer Stem Cells by T Lymphocytes
- (2009) M. Todaro et al. JOURNAL OF IMMUNOLOGY
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- WT-1 expression in gastrointestinal stromal tumours
- (2009) Gu-Hyun Kang et al. PATHOLOGY
- Expression of Stem Cell Markers in the Human Fetal Kidney
- (2009) Sally Metsuyanim et al. PLoS One
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens
- (2009) Qijin Xu et al. STEM CELLS
- Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer
- (2008) Martin Loos et al. CANCER LETTERS
- MCF7 Side Population Cells with Characteristics of Cancer Stem/Progenitor Cells Express the Tumor Antigen MUC1
- (2008) K. Engelmann et al. CANCER RESEARCH
- Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression
- (2008) R. F. Hwang et al. CANCER RESEARCH
- “Cancer Antigen WT1 Protein-Derived Peptide”-Based Treatment of Cancer -Toward the Further Development
- (2008) Yoshihiro Oka et al. CURRENT MEDICINAL CHEMISTRY
- Randomized Phase III Trial of Adjuvant Chemotherapy with Gemcitabine versus S-1 in Patients with Resected Pancreatic Cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01)
- (2008) A. Maeda et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
- (2008) Naomi N. Hunder et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo
- (2008) N Wagner et al. ONCOGENE
- Role of the Wilms’ tumour transcription factor, Wt1, in blood vessel formation
- (2008) Holger Scholz et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started